Two Sigma Investments
DYN icon

Two Sigma Investments’s Dyne Therapeutics DYN Stock Holding History

Two Sigma Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-159,154
Closed -$5.62M – 3163
2024
Q2 		$5.62M Buy
159,154
+150,242
+1,686% +$4.37M 0.01% 956
2024
Q1 		$253K Buy
+8,912
New +$202K ﹤0.01% 2623
2023
Q4 		– Sell
-24,400
Closed -$219K – 3206
2023
Q3 		$219K Sell
24,400
-8,100
-25% -$87.2K ﹤0.01% 2605
2023
Q2 		$366K Sell
32,500
-126,487
-80% -$1.49M ﹤0.01% 2459
2023
Q1 		$1.83M Buy
158,987
+3,638
+2% +$47.2K 0.01% 1430
2022
Q4 		$1.8M Buy
155,349
+138,325
+813% +$1.6M 0.01% 1365
2022
Q3 		$216K Buy
+17,024
New +$195K ﹤0.01% 2082
2022
Q2 		– Sell
-26,722
Closed -$258K – 2618
2022
Q1 		$258K Sell
26,722
-101,007
-79% -$860K ﹤0.01% 2268
2021
Q4 		$1.52M Buy
127,729
+14,525
+13% +$204K ﹤0.01% 2181
2021
Q3 		$1.84M Buy
+113,204
New +$2.01M ﹤0.01% 2067
2021
Q2 		– Sell
-26,000
Closed -$404K – 4155
2021
Q1 		$404K Buy
+26,000
New +$503K ﹤0.01% 3115

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Two Sigma Investments's DYN Position: Q3 2024 in Review

Two Sigma Investments sold out of Dyne Therapeutics (DYN) in Q3 2024, closing a stake of 159,154 shares — an estimated $5.62M sold.

Two Sigma Investments first reported a position in DYN in Q1 2021 and held it in 11 quarters. The position peaked at $5.62M in Q2 2024. 200 funds tracked by Wall St. Rank hold DYN as of Q3 2024.

  • Two Sigma Investments reported no remaining Dyne Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Investments sold 159,154 Dyne Therapeutics shares in Q3 2024, an estimated $5.62M.
  • Two Sigma Investments first reported a position in Dyne Therapeutics in Q1 2021 and held it in 11 quarters.
  • Two Sigma Investments's Dyne Therapeutics position peaked at $5.62M in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.